Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

Mefunidone decreased collagen I, collagen III, α-smooth muscle actin (α-SMA) and fibronectin (FN) expression in the obstructive kidneys after UUO at 14 days. by Chunyan Liu (44864)

Mean (± SE) percent survival of female western mosquitofish in the presence of a predator based on stage of pregnancy and availability of refuge. by Clinton T. Laidlaw (653664)

ALT concentrations of all individuals and the mean concentration of each group with 95%CI on each day before maximum concentrations. by Nattapat Nitinai (17896679)

Subjects:

Platelet count of all individuals and the mean concentration of each group with 95%CI on each day before the peak values. by Nattapat Nitinai (17896679)

Subjects:

AST concentrations of all individuals and the mean concentration of each group with 95%CI on each day before maximum concentrations. by Nattapat Nitinai (17896679)

Subjects:

Reduction of GC B cells decreases the number of Tfh cells in NZB/W F1 mice. by Isharat Yusuf (354734)

Inhibition of TMEM16A decreased SW620 cell migration and invasion. by Yujie Sui (549090)

BRAF and MEK inhibitor combination decreases rat skin lesion formation and increases tumor growth inhibition. by Alastair J. King (430098)

Chlorogenic acid (CGA) metabolites-containing serum from CGA-treated normal mice decreases lipid accumulation and stimulates cholesterol efflux from RAW264.7 cells. by Chongming Wu (169161)

Combined therapeutic treatment with 2ME2 and SD-208 additively decreases bone metastases in mice. by Lauren K. Dunn (260121)

Full-length PRR expression increases and sPRR secretion decreases in the absence of PACE4 in mouse. by Amro H. Mohammad (15081540)

Mean platelet volume and neutrophil to lymphocyte ratio decrease in patients with depression with antidepressant treatment by AHMET ÖZTÜRK (8077292)

The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution. by Pia Steensland (362091)

“…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”

The NK1-receptor antagonist ezlopitant significantly and selectively decreases voluntary intake of both sucrose and ethanol. by Pia Steensland (362091)

“…<p>Ezlopitant decreased consumption of 5% sucrose (<b>A</b>), whereas only the highest dose of ezlopitant (10 mg/kg) decreased consumption of 20% ethanol (<b>B</b>). …”

<i>In vivo</i> treatment with entinostat decreases Foxp3 expression in Tregs and inhibits Tregs function. by Li Shen (110858)

“…Cells were harvested from spleens and lymph nodes. A, <i>In vivo</i> entinostat treatment decreased the expression level of Foxp3 in CD4⁺Foxp3⁺ (Treg) cells. …”

Inhibition of VEGF and CaMKII in OS cells dramatically decreases tumor growth <i>in vivo</i>. by Paul G. Daft (720351)

Blocking ICOS but not CD28 signaling results in decreased Tfh in the maintenance phase of the SRBC immunization model. by Isharat Yusuf (354734)

Downregulation of βig-h3 decreases adhesion, invasion and migration of human osteosarcoma cells in vitro. by Yun-Shan Guo (530568)

CFG decreases TGF- β 1-induced invasion and migration of HEY and SKOV3 cells in vitro. by Fangfang Tao (408131)